Deutsche Hirntumorhilfe e.V. - Facebook

Hirntumor-Informationstag 2018


Surviving Terminal Cancer

19 Jahre Glioblastom – für die meisten Patienten mit dieser Erkrankung hört sich das schier unglaublich an. Denn ein Glioblastom ist in aller Regel mit einer weniger günstigen Prognose verbunden. Trotz Therapie leiden die meisten Patienten binnen des ersten Jahres nach Diagnose wieder an einem Rezidiv.

This film charts the remarkable story of Ben Williams, professor emeritus of experimental psychology at University of California, San Diego.


Diagnosed in 1995 with the most lethal cancer known to medicine, a primary brain tumour called glioblastoma multiforme, he was given just a few months to live. But a natural born maverick, and rigorous scientist, Ben decided he would not go down without a fight. Nineteen years later his story is an inspiration to patients the world over, whilst his case is dismissed by the medical community as just one of a handful of statistical outliers.


This documentary presents compelling evidence, from doctors, regulators, and other patients, that raise concern over the validity and ethical grounding of oncology research, and the resulting limitations to clinical practice. Is it possible that as a society we could make dramatic progress against cancer if we reconsidered our strategy, as opposed to blindly following a system that has failed to deliver meaningful results in most deadly cancers for over four decades? With such a delicate and complex subject, we have tried to maintain objectivity whilst asking questions which are long overdue in the public domain.


This film has been funded privately, following the death of a young family member to glioblastoma multiforme. We have decided to make the film available for free so that all cancer patients, whatever their economic background, can access what we feel is critical information for everyone to know upon diagnosis.


ASCO-News 2018

32.000 Experten aus allen Bereichen der Onkologie in Chicago

> mehr

Fortschritte in der Neurochirurgie

Zusätzliche Resektion, Pseudoprogression und vieles mehr

> mehr

NOA-Studien 2018

Update klinischer Studien von der NOA-Jahrestagung aus Köln

> mehr